• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：免疫细胞联合NLRP3炎性小体抑制剂对胰腺导管腺癌具有更好的抗肿瘤作用。

Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.

作者信息

Liu Hailiang, Xu Yong, Liang Kai, Liu Rong

机构信息

Department of Burn and Plastic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China.

The Second Hepatobiliary Surgical Department, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

Front Oncol. 2021 Dec 22;11:817747. doi: 10.3389/fonc.2021.817747. eCollection 2021.

DOI:10.3389/fonc.2021.817747
PMID:35004334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8728366/
Abstract

[This corrects the article DOI: 10.3389/fonc.2020.01378.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2020.01378。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7134/8728366/af139d47602c/fonc-11-817747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7134/8728366/c64ea505c74c/fonc-11-817747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7134/8728366/af139d47602c/fonc-11-817747-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7134/8728366/c64ea505c74c/fonc-11-817747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7134/8728366/af139d47602c/fonc-11-817747-g005.jpg

相似文献

1
Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.勘误：免疫细胞联合NLRP3炎性小体抑制剂对胰腺导管腺癌具有更好的抗肿瘤作用。
Front Oncol. 2021 Dec 22;11:817747. doi: 10.3389/fonc.2021.817747. eCollection 2021.
2
Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.免疫细胞联合NLRP3炎性小体抑制剂对胰腺导管腺癌具有更好的抗肿瘤作用。
Front Oncol. 2020 Aug 21;10:1378. doi: 10.3389/fonc.2020.01378. eCollection 2020.
3
3,4-Methylenedioxy-β-Nitrostyrene Ameliorates Experimental Burn Wound Progression by Inhibiting the NLRP3 Inflammasome Activation.3,4-亚甲二氧基-β-硝基苯乙烯通过抑制NLRP3炎性小体激活改善实验性烧伤创面进展。
Plast Reconstr Surg. 2016 Mar;137(3):566e-575e. doi: 10.1097/01.prs.0000479972.06934.83.
4
3,4-methylenedioxy-β-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome.3,4-亚甲二氧基-β-硝基苯乙烯通过阻断炎性小体的组装来抑制NLRP3炎性小体的激活。
J Biol Chem. 2014 Jan 10;289(2):1142-50. doi: 10.1074/jbc.M113.515080. Epub 2013 Nov 21.
5
The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.MCC950 抑制 NLRP3 炎性小体对 LPS 诱导的胰腺腺癌细胞炎症的影响。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2219-2229. doi: 10.1007/s00432-020-03274-y. Epub 2020 Jun 7.
6
Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma.勘误：KPNA4在胰腺导管腺癌中的临床相关性的系统表征。
Front Oncol. 2023 Sep 11;13:1282120. doi: 10.3389/fonc.2023.1282120. eCollection 2023.
7
Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas.勘误：用于胰腺导管腺癌诊断和预后的血清生物标志物组合
Front Oncol. 2021 Oct 6;11:774861. doi: 10.3389/fonc.2021.774861. eCollection 2021.
8
Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.勘误：肿瘤治疗电场联合轻度热疗作为胰腺癌新型辅助治疗方法的建立
Front Oncol. 2022 Mar 31;12:889215. doi: 10.3389/fonc.2022.889215. eCollection 2022.
9
Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.勘误：基于套索算法得出的预后模型预测50岁以上晚期胰腺导管腺癌患者的癌症特异性生存率：一项基于监测、流行病学和最终结果（SEER）数据库研究的回顾性研究
Front Oncol. 2024 Feb 7;14:1370998. doi: 10.3389/fonc.2024.1370998. eCollection 2024.
10
Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancer.勘误：建立肿瘤治疗电场联合轻度热疗作为胰腺癌的新型辅助治疗方法。
Front Oncol. 2024 Feb 29;14:1343421. doi: 10.3389/fonc.2024.1343421. eCollection 2024.